Molecular pharmacology and physiology of nociceptin.
نویسندگان
چکیده
منابع مشابه
The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family.
The isolation of an opioid receptor-related clone soon led to the isolation and characterization of a new neuropeptide, termed orphanin FQ or nociceptin (OFQ/N). This heptadecapeptide binds to the NOP(1) (previously termed ORL1) receptor with exceedingly high affinity, but does not interact directly with classical opioid receptors. Functionally, the actions of OFQ/N are diverse and intriguing. ...
متن کاملMagnesium: physiology and pharmacology.
Magnesium has an established role in obstetrics and an evolving role in other clinical areas, in particular cardiology. Many of the effects involving magnesium are still a matter of controversy. Over the next decade, it is likely that improvements in the measurement of magnesium, a clearer understanding of the mechanisms of its actions and further results of clinical studies will help to elucid...
متن کاملJournal of Physiology and Pharmacology
Central nervous system peptide and amino acid modulation of luteinizing hormone and prolactin secretion in the pig. Influence of opioids on LH secretion in gilts during the estrous cycle. D. Schams: Reg~lation of bovine intra-luteal function by peptide hormones. We have utilized active immunization against growth hormone releasing factor (GRF) to investigate relationships among somatotropin (ST...
متن کاملPhysiology and pharmacology of erythropoietin.
Human erythropoietin (Epo) is a 30.4 kDa glycoprotein hormone composed of a single 165 amino acid residues chain to which four glycans are attached. The kidneys are the primary sources of Epo, its synthesis is controlled by hypoxia-inducible transcription factors (HIFs). Epo is an essential factor for the viability and proliferation of erythrocytic progenitors. Whether Epo exerts cytoprotection...
متن کاملPhysiology and pharmacology of plerixafor.
Autologous hematopoietic stem cell (HSC) transplantation is an important therapeutic option for patients with non-Hodgkin's lymphoma and multiple myeloma. The primary source of HSC is from the peripheral blood which requires mobilization from the bone marrow. Current mobilization regimens include cytokines such as G-CSF and/or chemotherapy. However not all patients mobilize enough HSC to procee...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Folia Pharmacologica Japonica
سال: 1999
ISSN: 0015-5691,1347-8397
DOI: 10.1254/fpj.114.347